GSK sets out plans for listing of consumer products venture

June 23 (Reuters) - Britain's GSK on Wednesday
unveiled a detailed plan to spin off its consumer healthcare
venture with Pfizer into a separate company by the
middle of next year, as the pharmaceutical giant sharpens its
focus on prescription medicines and vaccines.

The separation will be achieved by demerging at least 80% of
GSK's current 68% shareholding in the Consumer Healthcare
business to GSK shareholders, with the shares in the new entity
to list on the London Stock Exchange.

(Reporting by Pushkala Aripaka in Bengaluru and Ludwig Burger
in Frankfurt; editing by Jason Neely)